GlassScriptPhysician profile
Sheila Heinle
NPI 1003918244
$2,577.02
in general payments reported to CMS, 2019-2025
23 companies · $428 in 2025
The $428 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.15 · 2020: $96.28 · 2021: $211 · 2022: $773 · 2023: $515 · 2024: $465 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,407.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $524.88 | 2021-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $475.23 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $302.85 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $239.82 | 2020-2025 | Watchman Access System, Bodyguardian, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $162.93 | 2022-2025 | Ensite Precision, Cardiomems, Amplatzer Amulet |
| Irhythm Technologies, INC. | $147.16 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Impulse Dynamics (USA) INC. | $130.30 | 2022-2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.34 | 2022-2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $74.25 | 2022-2024 | |
| Biosense Webster, INC. | $68.63 | 2023-2024 | Carto 3 |
| Amgen INC. | $60.97 | 2022-2025 | Repatha, Repatha |
| Lantheus Medical Imaging, INC. | $44.33 | 2019-2021 | |
| Novo Nordisk INC | $41.48 | 2022-2024 | |
| Pfizer INC. | $40.70 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.02 | 2024 | Lifevest |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspiremd LTD | $25.84 | 2025 | Cguard Prime Carotid Stent System |
| Amarin Pharma, INC. | $23.07 | 2022 | |
| Kestra Medical Technology Services, INC. | $22.99 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $18.45 | 2021 | |
| Esperion Therapeutics, INC. | $16.44 | 2023 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $15.73 | 2023 | Inpefa |
| Elutia, INC. | $11.61 | 2021 | |
| Bardy Diagnostics, INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Heinle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.